Clinical Trial

Lutein, Zeaxathin, and Fish Oil Supplementation

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 30, 2025 (before its estimated May 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to learn the impact of lutein, zeaxanthin, and fish oil (LZF) supplementation in healthy adults. The main question it aims to answer is: Will supplementation with LZF improve macular pigment optical density (MPOD), cognitive performance and bone mass compared to controls after six months? Subjects with an MPOD \<.43 will significantly improve MPOD after 6-months of LZF supplementation. Consuming a LZFO supplement for 6-months will improve visual cognitive performance. Consuming a LZFO supplement for 6-months will improve bone density. Participants will be asked to take either a LZF supplement or placebo daily for 6 months.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-07-05.
Trial Details
NCT Number NCT06489873
Lead Sponsor Texas A&M University
Collaborators: Allen Foundation Inc.
Conditions Cognitive Performance, Age-Related Macular Degeneration, Bone Loss
Enrollment 80 participants
Start Date 2024-02-07
Primary Completion 2026-05-01 (estimated)
Study Completion 2026-05-01 (estimated)
Updated on ClinicalTrials.gov 2025-09-30